Article Information
History
- November 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jean Marc Schwob, MD1,
- Alix Miauton, MD1,
- Dusan Petrovic, PhD1,2,
- Jean Perdrix, MD1,
- Nicolas Senn, MD PhD1,3,
- Katia Jaton, MD PhD3,4,
- Opota Onya, PhD3,4,
- Alain Maillard, MD5,
- Gianni Minghelli, MD5,
- Jacques Cornuz, MD MPH1,3,
- Gilbert Greub, MD PhD3,4,
- Blaise Genton, MD PhD1,3 and
- Valérie D’Acremont, MD PhD1,3,5,*
- 1Center for primary care and public health (Unisanté)
- 2Imperial College London
- 3University of Lausanne
- 4Institute of microbiology, University hospital of Lausanne
- 4Vidy-Med
- 5Swiss Tropical and Public Health Institute
- ↵*Corresponding author; email: valerie.dacremont{at}unisante.ch
Posted November 24, 2020.
Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: a prospective comparative clinical trial
